Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BactiTox A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.3%   Bankruptcy risk   16.3% 10.9% 2.0% 0.7% 7.2% 11.1% 20.3% 17.8%   Credit score (0-100)   12 24 68 94 33 21 5 8   Credit rating   BB BB A AA BBB BB B B   Credit limit (kDKK)   0.0 0.0 1.2 1,111.8 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   54.5 332 9,194 7,143 23,747 -841 0.0 0.0   EBITDA   54.5 331 9,013 3,947 21,560 -2,032 0.0 0.0   EBIT   54.5 331 7,944 3,768 21,377 -2,214 0.0 0.0   Pre-tax profit (PTP)   52.9 327.9 7,922.7 3,388.5 21,226.3 -2,226.1 0.0 0.0   Net earnings   40.9 255.8 6,172.4 2,339.1 16,494.4 -1,680.5 0.0 0.0   Pre-tax profit without non-rec. items   52.9 328 7,923 3,389 21,226 -2,226 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 278 1,940 1,108 925 0.0 0.0   Shareholders equity total   42.9 245 6,417 8,756 431 -1,250 -1,650 -1,650   Interest-bearing liabilities   0.1 0.0 84.1 0.0 99.4 3,465 1,650 1,650   Balance sheet total (assets)   78.8 531 13,106 12,611 6,267 2,688 0.0 0.0   Net Debt   0.1 0.0 84.1 -400 -334 3,289 1,650 1,650     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   54.5 332 9,194 7,143 23,747 -841 0.0 0.0   Gross profit growth   0.0% 508.3% 2,671.4% -22.3% 232.5% 0.0% 0.0% 0.0%   Employees   0 0 1 5 5 2 0 0   Employee growth %   0.0% 0.0% 0.0% 400.0% 0.0% -60.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   79 531 13,106 12,611 6,267 2,688 0 0   Balance sheet change%   0.0% 574.0% 2,369.1% -3.8% -50.3% -57.1% -100.0% 0.0%   Added value   54.5 331.3 9,013.4 3,947.1 21,556.1 -2,031.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 -791 1,482 -1,014 -365 -925 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 99.9% 86.4% 52.8% 90.0% 263.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   69.3% 108.7% 116.6% 29.3% 226.5% -43.2% 0.0% 0.0%   ROI %   126.7% 230.3% 235.5% 49.4% 460.4% -110.4% 0.0% 0.0%   ROE %   95.3% 177.9% 185.3% 30.8% 359.1% -107.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   54.5% 46.1% 49.0% 69.4% 6.9% -31.7% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.2% 0.0% 0.9% -10.1% -1.5% -161.9% 0.0% 0.0%   Gearing %   0.3% 0.0% 1.3% 0.0% 23.1% -277.2% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2,456.1% 5,130.3% 59.6% 902.4% 303.7% 1.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.3 2.6 1.8 2.7 0.8 0.3 0.0 0.0   Current Ratio   3.3 2.6 1.9 2.8 0.9 0.4 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 399.8 433.4 176.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   54.9 328.8 6,142.4 6,816.5 -677.0 -2,175.1 -824.9 -824.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 9,013 789 4,311 -1,016 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 9,013 789 4,312 -1,016 0 0   EBIT / employee   0 0 7,944 754 4,275 -1,107 0 0   Net earnings / employee   0 0 6,172 468 3,299 -840 0 0